×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LXEO – lexeo therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/22
08:05 am
lxeo
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/22
07:30 am
lxeo
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/20
07:27 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Medium
Report
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
12/17
05:02 pm
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Medium
Report
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
12/15
05:52 pm
lxeo
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight [Yahoo! Finance]
Low
Report
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight [Yahoo! Finance]
12/11
08:07 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
12/10
08:45 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
12/9
06:08 pm
lxeo
Lexeo Therapeutics, Inc. (LXEO) Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript [Seeking Alpha]
Low
Report
Lexeo Therapeutics, Inc. (LXEO) Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/8
11:45 am
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
11/28
06:04 am
lxeo
Form EFFECT Lexeo Therapeutics, Inc.
Low
Report
Form EFFECT Lexeo Therapeutics, Inc.
11/26
04:30 pm
lxeo
Form 424B3 Lexeo Therapeutics, Inc.
Medium
Report
Form 424B3 Lexeo Therapeutics, Inc.
11/20
05:21 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
11/20
05:20 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
11/20
05:19 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: See Tai Sandi
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: See Tai Sandi
11/20
05:18 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Robertson Jenny
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Robertson Jenny
11/20
05:15 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: